Recipient immune repertoire and engraftment site influence the immune pathway effecting acute hepatocellular allograft rejection.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 19044209)

Published in Cell Transplant on January 01, 2008

Authors

Phillip H Horne1, Keri E Lunsford, Jon P Walker, Mitchel A Koester, Ginny L Bumgardner

Author Affiliations

1: Integrated Biomedical Science Graduate Program, College of Medicine, The Ohio State University Medical Center, Columbus, OH 43210-1250, USA.

Articles by these authors

Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant (2005) 1.52

Giant asymptomatic primary esophageal schwannoma. Ann Thorac Surg (2012) 1.23

Targeting LFA-1 and cd154 suppresses the in vivo activation and development of cytolytic (cd4-Independent) CD8+ T cells. J Immunol (2005) 0.99

Resident designed intern orientation to address the new ACGME Common Program Requirements for resident supervision. J Surg Educ (2013) 0.98

Targeting LFA-1 synergizes with CD40/CD40L blockade for suppression of both CD4-dependent and CD8-dependent rejection. Am J Transplant (2003) 0.94

The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant (2003) 0.92

Hippocampal gene expression changes during age-related cognitive decline. Brain Res (2008) 0.90

Equivalent pharmacokinetics of mycophenolate mofetil in African-American and Caucasian male and female stable renal allograft recipients. Am J Transplant (2003) 0.89

Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells. J Immunol (2008) 0.87

Disparate primary and secondary allospecific CD8+ T cell cytolytic effector function in the presence or absence of host CD4+ T cells. J Immunol (2007) 0.86

Cytotoxic effector function of CD4-independent, CD8(+) T cells is mediated by TNF-α/TNFR. Transplantation (2012) 0.85

Evidence for tissue-directed immune responses: analysis of CD4- and CD8-dependent alloimmunity. Transplantation (2004) 0.85

Predicting Mortality in Patients Developing Recurrent Hepatocellular Carcinoma After Liver Transplantation: Impact of Treatment Modality and Recurrence Characteristics. Ann Surg (2017) 0.85

Pancreas after kidney transplantation. J Am Soc Nephrol (2002) 0.85

Hand-assisted laparoscopic versus open nephrectomies in living donors. Can J Surg (2005) 0.85

Single-site laparoscopic living donor nephrectomy offers comparable perioperative outcomes to conventional laparoscopic living donor nephrectomy at a higher cost. Transplantation (2011) 0.84

CD8+ T cells negatively regulate IL-4-dependent, IgG1-dominant posttransplant alloantibody production. J Immunol (2010) 0.84

CD4+ T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody. Transplantation (2005) 0.83

Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction. Clin Transplant (2014) 0.81

Endoscopic mucosal resection for staging and treatment of early esophageal carcinoma: a single institution experience. Surg Endosc (2014) 0.81

Twenty years of renal transplantation at Ohio State University: the results of five eras of immunosuppression. Am J Surg (2003) 0.81

Reproduction and pregnancy in transplant recipients: current practices. Prog Transplant (2006) 0.81

Innate pathways of immune activation in transplantation. J Transplant (2010) 0.80

Endoscopic management of high-grade dysplasia and intramucosal carcinoma: experience in a large academic medical center. Surg Endosc (2014) 0.79

Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients. Transplantation (2007) 0.78

OKT3 (muromonab-CD3) associated hepatitis in a kidney transplant recipient. Transplantation (2002) 0.78

Groove Pancreatitis, a Masquerading Yet Distinct Clinicopathological Entity: Analysis of Risk Factors and Differentiation. Pancreas (2015) 0.77

Therapeutic endoscopic ultrasonography: intratumoral injection for pancreatic adenocarcinoma. Gastroenterol Res Pract (2013) 0.77

Genetic modification of hepatocytes towards hepatocyte transplantation and liver tissue engineering. Cell Transplant (2006) 0.77

Critical role for CD8 T cells in allograft acceptance induced by DST and CD40/CD154 costimulatory blockade. Am J Transplant (2004) 0.76

mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells. Transplantation (2016) 0.76

Unique CD8+ T Cell-Mediated Immune Responses Primed in the Liver. Transplantation (2016) 0.75

Simultaneous liver-kidney transplantation or liver transplantation alone for patients in need of liver transplantation with renal dysfunction. Curr Opin Organ Transplant (2016) 0.75

Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipients. Cell Transplant (2012) 0.75

Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma: Analysis of the National Inpatient Sample From 2007 to 2014. J Clin Gastroenterol (2022) 0.75

Simultaneous pancreas-kidney transplantation at a single center. Clin Transpl (2003) 0.75

Simultaneous pancreas-kidney transplantation: overview of the ohio state experience. Yonsei Med J (2004) 0.75

Magnetic resonance cholangiography with mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after T-tube removal in liver transplantation. J Comput Assist Tomogr (2004) 0.75

Magnetic resonance angiography for preoperative evaluation of potential kidney donors. J Surg Res (2004) 0.75

BK virus as a mediator of graft dysfunction following kidney transplantation. Curr Opin Organ Transplant (2017) 0.75

Evolution of immunosuppression in kidney transplantation: the Ohio State University experience. Clin Transpl (2005) 0.75